Bio-Works Technologies AB (publ) (NGM:BIOWKS)
Sweden · Delayed Price · Currency is SEK 2.800
-0.050 (-1.75%)
At close: Feb 4, 2026
Bio-Works Technologies AB Market Cap
Bio-Works Technologies AB has a market cap or net worth of 278.39 million as of February 5, 2026. Its market cap has increased by 270.28% in one year.
Market Cap
278.39M
Enterprise Value
256.87M
Revenue
46.43M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.80
Market Cap Chart
Since December 14, 2017, Bio-Works Technologies AB's market cap has increased from 241.45M to 278.39M, an increase of 15.30%. That is a compound annual growth rate of 1.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 278.39M | 8.18% |
| Dec 30, 2025 | 257.35M | 242.79% |
| Dec 30, 2024 | 75.08M | -72.87% |
| Dec 29, 2023 | 276.76M | -62.42% |
| Dec 30, 2022 | 736.44M | -23.21% |
| Dec 30, 2021 | 959.03M | 246.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ascelia Pharma AB | 329.86M |
| Mendus AB | 309.84M |
| Lipum AB | 294.85M |
| Intervacc AB | 293.78M |
| Xintela AB | 251.49M |
| Elicera Therapeutics AB | 248.99M |
| Magle Chemoswed Holding AB | 235.40M |
| AlzeCure Pharma AB | 228.68M |